BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25779225)

  • 1. The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors.
    Treven M; Koenig X; Assadpour E; Gantumur E; Meyer C; Hilber K; Boehm S; Kubista H
    Epilepsia; 2015 Apr; 56(4):647-57. PubMed ID: 25779225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model.
    Bloms-Funke P; Bankstahl M; Bankstahl J; Kneip C; Schröder W; Löscher W
    Neuropharmacology; 2022 Feb; 203():108884. PubMed ID: 34785163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stigmasterol can be new steroidal drug for neurological disorders: Evidence of the GABAergic mechanism via receptor modulation.
    Karim N; Khan I; Abdelhalim A; Halim SA; Khan A; Al-Harrasi A
    Phytomedicine; 2021 Sep; 90():153646. PubMed ID: 34280827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive allosteric modulation of GABA
    Sharma R; Nakamura M; Neupane C; Jeon BH; Shin H; Melnick SM; Glenn KJ; Jang IS; Park JB
    Eur J Pharmacol; 2020 Jul; 879():173117. PubMed ID: 32325146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels.
    Rundfeldt C; Netzer R
    Arzneimittelforschung; 2000 Dec; 50(12):1063-70. PubMed ID: 11190770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retigabine calms seizure-induced behavior following status epilepticus.
    Slomko AM; Naseer Z; Ali SS; Wongvravit JP; Friedman LK
    Epilepsy Behav; 2014 Aug; 37():123-32. PubMed ID: 25016241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine.
    Klinger F; Bajric M; Salzer I; Dorostkar MM; Khan D; Pollak DD; Kubista H; Boehm S; Koenig X
    Br J Pharmacol; 2015 Oct; 172(20):4946-58. PubMed ID: 26211808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparation.
    Dost R; Rundfeldt C
    Epilepsy Res; 2000 Jan; 38(1):53-66. PubMed ID: 10604606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticonvulsant retigabine suppresses neuronal K
    Stas JI; Bocksteins E; Jensen CS; Schmitt N; Snyders DJ
    Sci Rep; 2016 Oct; 6():35080. PubMed ID: 27734968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retigabine: the newer potential antiepileptic drug.
    Czuczwar P; Wojtak A; Cioczek-Czuczwar A; Parada-Turska J; Maciejewski R; Czuczwar SJ
    Pharmacol Rep; 2010; 62(2):211-9. PubMed ID: 20508276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retigabine - a new antiepileptic drug with a different mechanism of action].
    Zwierzyńska E; Pietrzak B
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():973-81. PubMed ID: 24088541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effect of retigabine during postnatal development in rats.
    Forcelli PA; Soper C; Lakhkar A; Gale K; Kondratyev A
    Epilepsy Res; 2012 Aug; 101(1-2):135-40. PubMed ID: 22483539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex.
    van Rijn CM; Willems-van Bree E
    Eur J Pharmacol; 2003 Mar; 464(2-3):95-100. PubMed ID: 12620500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA beyond the synapse: defining the subtype-specific pharmacodynamics of non-synaptic GABA
    Lagrange AH; Hu N; Macdonald RL
    J Physiol; 2018 Sep; 596(18):4475-4495. PubMed ID: 30019335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Tonic GABA Currents by Anion Channel and Connexin Hemichannel Antagonists.
    Ransom CB; Ye Z; Spain WJ; Richerson GB
    Neurochem Res; 2017 Sep; 42(9):2551-2559. PubMed ID: 28401401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional GABAA receptor heterogeneity of acutely dissociated hippocampal CA1 pyramidal cells.
    Tietz EI; Kapur J; Macdonald RL
    J Neurophysiol; 1999 Apr; 81(4):1575-86. PubMed ID: 10200193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoterpene α-thujone exerts a differential inhibitory action on GABA(A) receptors implicated in phasic and tonic GABAergic inhibition.
    Czyzewska MM; Mozrzymas JW
    Eur J Pharmacol; 2013 Feb; 702(1-3):38-43. PubMed ID: 23376563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc Selectively Blocks Neurosteroid-Sensitive Extrasynaptic δGABAA Receptors in the Hippocampus.
    Carver CM; Chuang SH; Reddy DS
    J Neurosci; 2016 Aug; 36(31):8070-7. PubMed ID: 27488628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.
    Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K
    Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.